September 02, 2015

On September 1, 2015, the Honorable Douglas P. Woodlock of the United States District Court for the District of Massachusetts indicated he was likely to deny a Pfizer motion for summary judgment in a long-running False Claims Act case alleging that Wyeth, which was acquired by Pfizer in 2009, falsely inflated the price it reported to the government of its drug Protonix Oral.  Judge Woodlock set a trial date in this case of March 7, 2016.

These claims were initiated by two whistleblowers under the False Claims Act, and have resulted in the intervention of the United States and thirty-six individual states and the District of Columbia – believed to be more states than have ever intervened in any U.S. qui tam lawsuit. The Department of Justice previously indicated in a court filing that damages in the case could exceed $2 billion dollars.

One of the whistleblowers in this matter, Lauren Kieff, is represented by Cohen Milstein Sellers & Toll PLLC. 

Related Articles

Mass. Judge Says Pfizer Whistleblower Suit Likely To Proceed
September 2, 2015

Pfizer Suffers Setback in Trying to Toss Medicaid Lawsuit
The Wall Street Journal
September 1, 2015